Systolic hypertension in the elderly: Arterial wall mechanical properties and the renin-angiotensin-aldosterone system

Journal of Hypertension

Volumn 23, Issue 4, 2005, Pages 673-681

  Safar, Michel E ^a  

^a HÔTEL DIEU   (France)

Author keywords

Arterial wall mechanics; Elderly; Reninangiotensin system; Systolic hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; COLLAGEN FIBER; RENIN; SODIUM;

AGE; AGED; ARTERY WALL; CARDIOVASCULAR RISK; ENDOTHELIUM LESION; GENETIC POLYMORPHISM; GERIATRIC DISORDER; HIGH SODIUM INTAKE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTOLIC HYPERTENSION;

EID: 17144417345     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000163130.39149.fe     Document Type: Review

References (74)

1. Nichols WW, O'Rourke M. McDonald's blood flow in arteries. In: Theoretical, Experimental and Clinical Principles, 4th edition. London: Arnold E.; 1998, pp. 54-113, 201-222, 284-292, 347-401.
2. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355:865-872.
3. Black HR. The paradigm has shifted to systolic blood pressure. Hypertension 1999; 34:386-387.
4. Stamler J, Rose G, Stamler R, Elliot P, Dyer A, Marmot M. INTERSALT study findings. Public health and medical care implications. Hypertension 1989; 14:570-577.
5. Simon G. Synergistic effect of angiotensin II and a high sodium diet on the vascular glycosaminoglycan synthesis of rats. Am J Hypertens 1997; 10:1216-1222.
6. Simon G. Pathogenesis of structural vascular changes in hypertension. J Hypertens 2004; 22:3-10.
7. Simpson FO. Blood pressure and sodium intake. In: Bulpitt CJ, editor. Handbook of hypertension: epidemiology of hypertension. Amsterdam: Elsevier; 2000, pp. 274-295.
8. Muntzel M, Drueke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992; 5:1S-42S.
9. Niarchos AP, Weinstein DL, Laragh JH. Comparison of effects of diuretic therapy and low sodium intake on isolated systolic hypertension. Am J Med 1984; 77:1061-1068.
10. du Cailar G, Mimram A, Fesler P, Ribstein J, Blacher J, Safar ME. Dietary sodium and pulse pressure in normotensive and essential hypertensive subjects. J Hypertens 2004; 22:697-703.
11. Simpson FO. Salt and hypertension: current data, attitudes and policies. J Cardiovasc Pharmacol 1984; 6:S4-S9.
12. Simon G, Illyes G, Csiky B. Structural vascular changes in hypertension. Role of angiotensin II, dietary sodium supplementation, blood pressure and time. Hypertension 1998; 32:654-660.
13. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43:142-146.
14. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003; 107:490-497.
15. Safar ME, Blacher J, Mourad JJ, London GM. Stiffness of carotid artery wall material and blood pressure in humans. Stroke 2000; 31:782-790.
16. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95:588-593.
17. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension. Role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36:312-318.
18. Chamiot-Clerc P, Renaud JF, Safar ME. Pulse pressure, aortic reactivity and endothelium dysfunction in old hypertensive rats. Hypertension 2001; 37:313-321.
19. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, et al. Effect of chronic ANG I-converting enzyme inhibition of aging processes. II. Larges arteries. Am J Physiol 1994; 267:R124-R135.
20. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21:1055-1076.
21. Van Bortel LM, Struijker-Boudier HA, Safar ME. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001; 38:914-921.
22. Asmar RG, London GM, O'Rourke ME, Safar ME, for the Reason project coordinators and investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/ indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 2001; 38:922-926.
23. Chen CH, Ting CT, Lin SJ, Hsu FCP, Siu CO, Chou P, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive. Hypertension 1995; 25:1034-1041.
24. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991; 9:17-22.
25. Young M, Fulllerton M, Dilley R, Funder J. Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 1994; 93:2578-2583.
26. Weber KT, Brilla CG, Campbell SE, Guarda E, Zhou G, Sriram K. Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol 1993; 88(suppl 1):107-124.
27. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992; 26:671-677.
28. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993; 27:341-348.
29. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy B, Safar M, Benetos A. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 1994; 23:74-82.
30. Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting-enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997; 17:3196-3201.
31. Labat C, Lacolley P, Lajemi M, De Gasparo M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 2001; 38:439-443.
32. Safar ME, Thuilliez C, Richard V, Benetos A. Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res 2000; 46:269-276.
33. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats (SHRs). Arterioscler Thromb Vasc Biol 1997; 17:1152-1156.
34. Lacolley P, Safar ME, Lucet B, Ledudal K, Labat C, Benetos A. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol 2001; 37:662-667.
35. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt treated rats - effects of eplerenone. Circulation 2002; 106:2848-2853.
36. Contard F, Sabri A, Glukhova M, Sartore S, Marotte F, Pomies J, et al. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 1993; 22:665-676.
37. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107:2864-2869.
38. Laurent S, Caviezel B, Beck L, Girerd X, Billaud E, Boutouyrie P, et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension 1994; 23:878-883.
39. Bezie Y, Lamazière J-M, Laurent S, Challande P, Sa Cunha R, Bonnet J, Lacolley P. Fibronectine expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1998; 18:1027-1034.
40. Langille BL. Arterial remodelling: relation to hemodynamics. Can J Pharmacol 1996; 74:834-841.
41. Huijberts MS, Wolffenbuttel BH, Struijker-Boudier HA, Crijns FR, Kruseman AC, Poitevin P, Levy BI. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest 1993; 92:1407-1411.
42. Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 1998; 95:4630-4634.
43. Corman B, Duriez M, Poitevin P, Heudes D, Bruneval P, Tedgui A, Levy BI. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci USA 1998; 95:1301-1306.
44. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, Degroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104:1464-1470.
45. Simon G. Experimental evidence for blood pressure-independent vascular effects of high sodium diet. Am J Hypertens 2003; 16:1074-1708.
46. Bevan JA. Flow regulation of vascular tone. Its sensitivity to changes in sodium and calcium. Hypertension 1993; 22:273-281.
47. Siegel G, Walter A, Bostanjoglo M, Jans WH, Kinne R. Binding of mono-and divalent cations to different components of extracellular matrix. Abh Rheinisch-Westfael Akad Wiss 1989; 82:155-170.
48. Gandley RE, Mclaughlin MK, Koob TJ, Little SA, Mcguffee LJ. Contribution of chondroitin-dermatan sulfate-containing proteoglycans to the function of rat mesenteric arteries. Am J Physiol 1997; 273:H952-H960.
49. Et-Taouil K, Schiavi P, Levy BI, Plante GE. Sodium intake, large artery stiffness and proteoglycans in the SHR. Hypertension 2001; 38:1172-1176.
50. Lacolley P, Challande P, Boumaza S, Cohuet G, Laurent S, Boutouyrie P, et al. Mechanical properties and structure of carotid arteries in mice lacking desmin. Cardiovasc Res 2001; 51:178-187.
51. Louis H, Li Z, Labat C, Lamaziere JM, Glucova M, Gardner H, Lacolley P. Defects in vascular smooth muscle hypertrophic response to angiotensin II in integrin α1 knockout mice [Abstract]. Hypertension 2004; 43: 1349.
52. Bardy N, Karillon GJ, Merval R, Samuel JL, Tedgui A. Differential effects of pressure and flow on DNA and protein synthesis and on fibronectin expression by arteries in a novel organ culture system. Circ Res 1995; 77:684-694.
53. Bouillier H, Samain E, Rucker-Martin C, Renaud JF, Safar M, Dagher G. Effect of extracellular matrix elements on angiotensin II-induced calcium release in vascular smooth muscle cells from normotensive and hypertensive rats. Hypertension 2001; 37:1465-1472.
54. Cohuet G, Challande P, Osborne-Pellegrin M, Arribas SM, Dominiczack A, Louis H, et al. Mechanical strength of the isolated carotid artery in SHR. Hypertension 2001; 38:1167-1171.
55. London GM, Asmar RG, O'Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43:92-99.
56. Latham RD, Westerhof M, Skipema P, Rubal BJ, Reuderink P, Murgo JP. Regional wave travel and reflections along human aiorta: a study with 6 silmutaneous micromanometric pressures. Circulation 1985; 72:1257-1269.
57. Blacher J, Guerin A, Pannier B, Marchais SJ, London GM, Safar ME. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38:938-942.
58. Luft FC. Molecular genetics of human hypertension. J Hypertens 1998; 16:1871-1878.
59. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. Influence of angiotensin-converting enzyme and angiotensin II type I receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94:698-703.
60. Mourad JJ, Ducailar G, Rudnichi A, Lajemi M, Mimram A, Safar ME. Age-related increase of pulse pressure and gene polymorphisms in essential hypertension: a preliminary study. J Renin Angiotensin Aldosterone Syst 2002; 3:109-115.
61. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger H, Herrmann SM, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a caucasian population. J Hypertens 2001; 19:1349-1358.
62. Balkenstein EJ, Staessen JA, Wang JG, Van Der Heijden-Spek JJ, Van Bortel LM, Barlassina C, et al. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 2001; 38:1190-1197.
63. Safar ME, Lajemi M, Rudnichi A, Asmar R, Benetos A. Angiotensin- converting enzyme D/I gene polymorphism and age-related changes in pulse pressure insubjects with hypertension. Arterioscler Thromb Vasc Biol 2004; 24:782-786.
64. Rudnichi A, Safar ME, Lajemi M, Benetos A. Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension. Am J Hypertens 2004; 17:321-327.
65. Dubay C, Vincent M, Samani N, Hubert P, Kaiser MA, Beressi JP, et al. Genetic determinants of diastolic and pulse pressure: map to different loci in Lyon hypertensive rats. Nat Genet 1993; 3:354-357.
66. Macmahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
67. Prospective Studies Collaboration. Age specific relevance of usual blood pressure to vascular mortality: one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
68. Darné B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989; 13:392-400.
69. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735-738.
70. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muisan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235.
71. Duchier J, Iannascoli F, Safar M. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic hypertension in the elderly. Am J Cardiol 1987; 60:99-102.
72. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC mild hypertension trial. J Hypertens 1999; 17:1065-1072.
73. Cushman WC, Materson BJ, Williams DW, Reda DJ, for the Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Pulse pressure changes with six classes of antihypertensive agents in a randomized controlled trial. Hypertension 2001; 38:953-957.
74. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103:987-992.